Results 201 to 210 of about 12,832,564 (302)

Thrombolysis in non-ST-elevation myocardial infarction: systematic review and meta-analysis of randomised controlled trials. [PDF]

Open Heart
de Alencar JN, Oliveira MHJ, Bulhoes E, Farias CA, Kabariti JC, Carvalho HC, Meyers HP, Smith SW.   +7 more
europepmc   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

Journal of Internal Medicine, EarlyView.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen, Annette Kopp‐Schneider, Tomislav Vlaski, Sigrid Carlsson, Peter Hallermann, Ludmilla Jewlanowa, Jana Barinoff, Valentin Goede, Christian Lüders, Thomas Kiefer‐Trendelenburg, Diana Lüftner, Jasmin Doll, Jürgen Wagner, Birgit Leibbrand, Hermann Brenner, Ben Schöttker   +15 more
wiley   +1 more source

Acute Non-ST-Elevation Myocardial Infarction in a 26-Year-Old Woman: A Case Report. [PDF]

Cureus
Sharma M, Sapkota S, Surani S, Gaalla AM, Chandna N.   +4 more
europepmc   +1 more source

Early Urinary Sodium Levels May Predict the Extent of Myocardial Injury and Need for Decongestive Therapy in Non-ST-Elevation Myocardial Infarction. [PDF]

Anatol J Cardiol
Kozluca V, Özyüncü N, Atan Ş, Özerdem ME, Latifoğlu A, Akbulut Koyuncu İM, Esenboğa K, Tutar E.   +7 more
europepmc   +1 more source

Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond

Obesity Reviews, EarlyView.
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed, Juan S. Barajas‐Gamboa, Mohammad Zubaid, Ebaa Al Ozairi, Abdullah Shehab, Khalid Al‐Rasadi, Charbel Abi Khalil, Noor Al Busaidi, Fahad Al Sindi, Zuhier Awan, Tomader Ali, Khaldoon Al‐Humood, Fatheya Al Awadi, Mohammed Al Hadad, Manal Al Kindi, Khalid Al Habib, Khalid Al Waili, Maryam Alsaeed, Adel Tash, Hani Sabbour   +19 more
wiley   +1 more source

Management of non-ST-elevation myocardial infarction: A constant challenge

Revista Portuguesa de Cardiologia (English Edition), 2016
openaire   +2 more sources

Five-year retrospective analysis of invasive <i>vs.</i> conservative strategies for non-ST elevation myocardial infarction in critically ill cancer patients. [PDF]

Cardiovasc Diagn Ther
Timuroglu A, Ceren I.
europepmc   +1 more source

Epigenomic Cascades Across Organs in Metabolic Dysfunction–Associated Steatotic Liver Disease: New Therapeutic Horizons

Obesity Reviews, EarlyView.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang, Zhongyu Huang, Sanchun Tan, Fengxia Liang, Li Chen   +4 more
wiley   +1 more source

Non-ST elevation myocardial infarction with multivessel disease and anoxic brain injury: a case report. [PDF]

Future Cardiol
Moses H, Mohammadi A, Jilani TN.
europepmc   +1 more source